Skip to content
The Policy VaultThe Policy Vault

PegasysMedica

Chronic Hepatitis C Virus (HCV) – Awaiting Liver Transplantation, Any Viral Genotype, Pediatric and Adolescents (≥ 2 years and ≤ 17 years of age)

Initial criteria

  • age ≥ 2 years and ≤ 17 years
  • medication is prescribed in combination with ribavirin unless there is a contraindication or intolerance to ribavirin according to the prescriber
  • medication is prescribed by or in consultation with a gastroenterologist, hepatologist, infectious diseases physician, or liver transplant physician affiliated with a liver transplant center

Approval duration

12 months